• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受慢性血液透析患者外周血单个核细胞的抑制细胞活性

Suppressor cell activity of peripheral mononuclear cells from patients undergoing chronic haemodialysis.

作者信息

Guillou P J, Woodhouse L F, Davison A M, Giles G R

出版信息

Biomedicine. 1980 Feb;32(1):11-7.

PMID:6445213
Abstract

The enhanced in vitro proliferative response of peripheral mononuclear cells (PMNC) when pre-cultured for 24 hours prior to the addition of Concanavalin-A has been used as an indirect parameter of suppressor cell activity in healthy subjects and in patients undergoing chronic haemodialysis. The proliferative response of PMNC from haemodialysis patients is lower than that of control subjects when Con-A is added at the initiation of culture but approximates to that of normal subjects when the addition of Con-A was deferred for 24 hours. The Suppressor Indices of PMNC from haemodialysis patients were at least as great and sometimes greater than those of control subjects but the absolute T-cell counts were lower in haemodialysis patients than in controls. These results suggest that the relative energy of haemodialysis patients is partly attributable to T-cell depletion but this is accompanied by retention, and in some cases augmentation, of suppressor cell activity.

摘要

在添加刀豆蛋白-A之前将外周血单个核细胞(PMNC)预培养24小时后,其体外增殖反应增强,这已被用作健康受试者和接受慢性血液透析患者中抑制细胞活性的间接参数。当在培养开始时添加刀豆蛋白-A时,血液透析患者的PMNC增殖反应低于对照组,但当刀豆蛋白-A的添加推迟24小时时,其增殖反应接近正常受试者。血液透析患者的PMNC抑制指数至少与对照组一样大,有时甚至大于对照组,但血液透析患者的绝对T细胞计数低于对照组。这些结果表明,血液透析患者的相对能量部分归因于T细胞耗竭,但同时伴随着抑制细胞活性的保留,在某些情况下还会增强。

相似文献

1
Suppressor cell activity of peripheral mononuclear cells from patients undergoing chronic haemodialysis.接受慢性血液透析患者外周血单个核细胞的抑制细胞活性
Biomedicine. 1980 Feb;32(1):11-7.
2
T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation.接受慢性血液透析患者的T细胞:促有丝分裂反应、抑制活性以及白细胞介素-2的产生和受体生成
Diagn Immunol. 1986;4(4):209-16.
3
Suppressor cell numbers and activity in non-transfused renal dialysis patients.未输血的肾透析患者中抑制细胞的数量和活性
Clin Nephrol. 1983 Sep;20(3):130-5.
4
Suppressor T cell numbers and function in atopic patients with high serum IgE levels.血清IgE水平高的特应性患者中抑制性T细胞的数量和功能。
J Clin Lab Immunol. 1983 Dec;12(4):179-85.
5
Lymphocyte subpopulations and suppressor cell activity in acute polyradiculoneuritis (Guillain-Barré syndrome).急性多发性神经根神经炎(格林-巴利综合征)中的淋巴细胞亚群及抑制细胞活性
Clin Exp Immunol. 1983 Mar;51(3):448-54.
6
Disordered immunoregulatory functions in patients with chronic active hepatitis.慢性活动性肝炎患者免疫调节功能紊乱
Clin Exp Immunol. 1982 Mar;47(3):595-605.
7
[Studies on immune deficiency in chronic renal failure. I. Lymphocyte subset and ConA-induced suppressor cell activity in chronic hemodialysis patients].[慢性肾衰竭免疫缺陷的研究。I. 慢性血液透析患者的淋巴细胞亚群及刀豆蛋白A诱导的抑制细胞活性]
Nihon Jinzo Gakkai Shi. 1988 Jun;30(6):713-9.
8
[Suppressor T-lymphocytes in continuously progressive juvenile schizophrenia].[持续性进行性青少年精神分裂症中的抑制性T淋巴细胞]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1984;84(7):1065-9.
9
Concanavalin A-activated suppressor cell activity in peripheral blood lymphocytes of urologic cancer patients.刀豆球蛋白A激活泌尿系统癌症患者外周血淋巴细胞中的抑制细胞活性。
J Natl Cancer Inst. 1980 Sep;65(3):553-7.
10
Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.活动期酒精性肝病中伴刀豆球蛋白A诱导的抑制性T细胞活性受损。
Gastroenterology. 1981 Mar;80(3):510-7.

引用本文的文献

1
Comparison of the risks of renal cell carcinoma or urothelial cancer between hemodialysis and peritoneal dialysis patients.血液透析和腹膜透析患者患肾细胞癌或尿路上皮癌风险的比较。
Int Urol Nephrol. 2023 Sep;55(9):2267-2274. doi: 10.1007/s11255-023-03534-z. Epub 2023 Mar 1.
2
The use of vaccines in renal failure.肾衰竭中疫苗的使用。
Clin Pharmacokinet. 1992 Jun;22(6):434-46. doi: 10.2165/00003088-199222060-00003.